However, survival analysis based on Kaplan–Meier Plotter (K–M Plotter) database showed that overall survival (OS) and first-progression (FP) survival of GC patients with low expression of HOXA11-AS were better than that of patients with high expression of HOXA11-AS (OS, P = 0.015, Fig. 1d; FP, P = 0.084, Fig. 1e). Here, HOXA11 is linked to gastric cancer.